Evidence map›Paper›PMID 41938759›Full record

ArticleNordisk alkohol- & narkotikatidskrift : NAT2026

What is the Addictive Potential from Vaping?

Karl Erik Lund, Tord Finne Vedøy

Abstract read
In one paragraph

Article in Nordisk alkohol- & narkotikatidskrift : NAT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Karl Erik LundDepartment of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway.ORCID https://orcid.org/0000-0002-4015-1167
Tord Finne VedøyDepartment of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway.ORCID https://orcid.org/0000-0001-9603-8940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: The present study discusses the addictive potential from vaping heuristically in view of existing research literature. We also paying attention to aayouth perspective in a Norwegian context. Methods: The study compiled paradigmatic explanations of addiction and then conducted a narrative review of the sparse literature on vape addiction. We draw som conclusions based on the results from a number of review-based viewpoints. Findings: Addiction to e-cigarettes or vapes is typically characterized by daily use, the first inhalation of the day occurring shortly after waking up, use of nicotine-containing e-liquid, continued use despite an expressed desire to abstain, acknowledgment that persistent use may lead to health harm and the experience of withdrawal symptoms following abrupt cessation. Higher frequency of use, longer duration of use, elevated nicotine concentration in the e-liquid, prior cigarette smoking and the use of pod-based e-cigarettes containing nicotine salts appear to be associated with a greater degree of dependence. Nicotine addiction among vapers may originate from previous smoking, although individuals without any smoking history also exhibit withdrawal symptoms. Overall, the level of addiction among vapers appears to be lower than that observed among smokers. Conclusions: Among Norwegian youth, e-cigarette use is generally experimental, transient and infrequent, and the use of nicotine-free products is common. It is therefore likely that a small segment of young vapers meets established criteria for addiction. Nevertheless, irregular use in the early stages may evolve into more dependency-driven patterns of use over time.

Indexed as

addictiondependenceE-cigarettesnicotinesmokingsnustobaccovaping

Identifiers

PMID41938759
PMCPMC13048976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.